A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2

L. McKendrick, D. W. Meek

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    The tumor suppressor protein p53 is phosphorylated at a C-terminal residue (serine 386 in mouse p53) by the protein kinase CK2. Phosphorylation by CK2 activates the specific DNA binding function of p53 and stimulates its ability to suppress cellular growth. Previous reports have suggested that phosphorylation of p53 at the CK2 site is stimulated in cells expressing the large tumor antigen (T antigen) of simian virus 40 (SV40). To test this idea, we have expressed a C-terminal p53 "mini-protein" which comprises amino acids 154-387 of mouse p53 and therefore lacks the heavily phosphorylated N-terminus. In addition, the serine 309 phosphorylation site (targeted by cyclin-dependent kinases) has been mutated to encode alanine. We have expressed the p53 mini-protein in mammalian cells and shown by phosphopeptide mapping that it is phosphorylated at a single physiological phosphorylation site, serine 386. Using this mini-protein as a cellular target for CK2, we have shown that phosphorylation of p53 by CK2 is not affected by the presence of T antigen. The p53 mini-protein is likely to be a useful tool with which to probe the regulation of p53 phosphorylation by CK2 in response to other factors which influence cell growth.
    Original languageEnglish
    Pages (from-to)555-561
    Number of pages7
    JournalCellular & Molecular Biology Research
    Volume40
    Issue number5-6
    Publication statusPublished - 1994

    Fingerprint

    Tumor Suppressor Protein p53
    Casein Kinase II
    Phosphorylation
    Serine
    Neoplasm Antigens
    Proteins
    Cells
    Phosphopeptides
    Simian virus 40
    Cyclin-Dependent Kinases
    Cell growth
    Growth
    Viruses
    Alanine
    Amino Acids
    DNA

    Cite this

    @article{110379a197874844bb6c6b494c370a48,
    title = "A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2",
    abstract = "The tumor suppressor protein p53 is phosphorylated at a C-terminal residue (serine 386 in mouse p53) by the protein kinase CK2. Phosphorylation by CK2 activates the specific DNA binding function of p53 and stimulates its ability to suppress cellular growth. Previous reports have suggested that phosphorylation of p53 at the CK2 site is stimulated in cells expressing the large tumor antigen (T antigen) of simian virus 40 (SV40). To test this idea, we have expressed a C-terminal p53 {"}mini-protein{"} which comprises amino acids 154-387 of mouse p53 and therefore lacks the heavily phosphorylated N-terminus. In addition, the serine 309 phosphorylation site (targeted by cyclin-dependent kinases) has been mutated to encode alanine. We have expressed the p53 mini-protein in mammalian cells and shown by phosphopeptide mapping that it is phosphorylated at a single physiological phosphorylation site, serine 386. Using this mini-protein as a cellular target for CK2, we have shown that phosphorylation of p53 by CK2 is not affected by the presence of T antigen. The p53 mini-protein is likely to be a useful tool with which to probe the regulation of p53 phosphorylation by CK2 in response to other factors which influence cell growth.",
    author = "L. McKendrick and Meek, {D. W.}",
    year = "1994",
    language = "English",
    volume = "40",
    pages = "555--561",
    journal = "Cellular & Molecular Biology Research",
    issn = "0968-8773",
    publisher = "Springer Verlag",
    number = "5-6",

    }

    A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2. / McKendrick, L.; Meek, D. W.

    In: Cellular & Molecular Biology Research, Vol. 40, No. 5-6, 1994, p. 555-561.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2

    AU - McKendrick, L.

    AU - Meek, D. W.

    PY - 1994

    Y1 - 1994

    N2 - The tumor suppressor protein p53 is phosphorylated at a C-terminal residue (serine 386 in mouse p53) by the protein kinase CK2. Phosphorylation by CK2 activates the specific DNA binding function of p53 and stimulates its ability to suppress cellular growth. Previous reports have suggested that phosphorylation of p53 at the CK2 site is stimulated in cells expressing the large tumor antigen (T antigen) of simian virus 40 (SV40). To test this idea, we have expressed a C-terminal p53 "mini-protein" which comprises amino acids 154-387 of mouse p53 and therefore lacks the heavily phosphorylated N-terminus. In addition, the serine 309 phosphorylation site (targeted by cyclin-dependent kinases) has been mutated to encode alanine. We have expressed the p53 mini-protein in mammalian cells and shown by phosphopeptide mapping that it is phosphorylated at a single physiological phosphorylation site, serine 386. Using this mini-protein as a cellular target for CK2, we have shown that phosphorylation of p53 by CK2 is not affected by the presence of T antigen. The p53 mini-protein is likely to be a useful tool with which to probe the regulation of p53 phosphorylation by CK2 in response to other factors which influence cell growth.

    AB - The tumor suppressor protein p53 is phosphorylated at a C-terminal residue (serine 386 in mouse p53) by the protein kinase CK2. Phosphorylation by CK2 activates the specific DNA binding function of p53 and stimulates its ability to suppress cellular growth. Previous reports have suggested that phosphorylation of p53 at the CK2 site is stimulated in cells expressing the large tumor antigen (T antigen) of simian virus 40 (SV40). To test this idea, we have expressed a C-terminal p53 "mini-protein" which comprises amino acids 154-387 of mouse p53 and therefore lacks the heavily phosphorylated N-terminus. In addition, the serine 309 phosphorylation site (targeted by cyclin-dependent kinases) has been mutated to encode alanine. We have expressed the p53 mini-protein in mammalian cells and shown by phosphopeptide mapping that it is phosphorylated at a single physiological phosphorylation site, serine 386. Using this mini-protein as a cellular target for CK2, we have shown that phosphorylation of p53 by CK2 is not affected by the presence of T antigen. The p53 mini-protein is likely to be a useful tool with which to probe the regulation of p53 phosphorylation by CK2 in response to other factors which influence cell growth.

    M3 - Article

    VL - 40

    SP - 555

    EP - 561

    JO - Cellular & Molecular Biology Research

    JF - Cellular & Molecular Biology Research

    SN - 0968-8773

    IS - 5-6

    ER -